Q32 Bio Stock Performance
| QTTB Stock | 2.32 0.07 2.93% |
On a scale of 0 to 100, Q32 Bio holds a performance score of 9. The firm owns a Beta (Systematic Risk) of -0.26, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Q32 Bio are expected to decrease at a much lower rate. During the bear market, Q32 Bio is likely to outperform the market. Please check Q32 Bio's value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to make a quick decision on whether Q32 Bio's current price history will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Q32 Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Q32 Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.93) | Five Day Return (15.02) | Year To Date Return (32.75) | Ten Year Return (99.31) | All Time Return (99.31) |
Last Split Factor 1:18 | Last Split Date 2024-03-26 |
1 | Disposition of 161323 shares by Kalowski Lee of Q32 Bio at 16.82 subject to Rule 16b-3 | 08/21/2025 |
2 | Acquisition by Lundberg Sven Ante of 23140 shares of Q32 Bio at 2.54 subject to Rule 16b-3 | 09/05/2025 |
3 | Disposition of 12767 shares by Tzianabos Arthur of Q32 Bio at 16.82 subject to Rule 16b-3 | 09/10/2025 |
4 | Earnings Risk Is Q32 Bio Inc. exposed to currency risks - July 2025 WrapUp Weekly Stock Breakout Alerts - khodrobank.com | 09/19/2025 |
5 | Q32 Bio Trades At Lows While Betting On Immune Breakthroughs - Finimize | 10/07/2025 |
6 | Acquisition by Manke Isaac of 12767 shares of Q32 Bio at 2.54 subject to Rule 16b-3 | 10/17/2025 |
7 | Acquisition by Laporte Kathleen of 53521 shares of Q32 Bio at 2.8 subject to Rule 16b-3 | 10/23/2025 |
8 | Is Q32 Bio Inc. stock reversal real or fake - July 2025 Levels Real-Time Buy Signal Alerts - newser.com | 10/28/2025 |
9 | Q32 Bio Inc. stock trendline breakdown - Portfolio Update Summary Daily Stock Trend Watchlist - newser.com | 11/06/2025 |
| Begin Period Cash Flow | 31.3 M | |
| Total Cashflows From Investing Activities | 19.9 M |
Q32 Bio Relative Risk vs. Return Landscape
If you would invest 163.00 in Q32 Bio on August 8, 2025 and sell it today you would earn a total of 69.00 from holding Q32 Bio or generate 42.33% return on investment over 90 days. Q32 Bio is currently generating 0.7415% in daily expected returns and assumes 6.2131% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than Q32, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Q32 Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Q32 Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Q32 Bio, and traders can use it to determine the average amount a Q32 Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1193
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | QTTB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.21 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.74 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Q32 Bio is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Q32 Bio by adding it to a well-diversified portfolio.
Q32 Bio Fundamentals Growth
Q32 Stock prices reflect investors' perceptions of the future prospects and financial health of Q32 Bio, and Q32 Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Q32 Stock performance.
| Return On Equity | -4.92 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | (10.89 M) | ||||
| Shares Outstanding | 12.2 M | ||||
| Price To Book | 3.55 X | ||||
| Gross Profit | (48.15 M) | ||||
| EBITDA | (45.3 M) | ||||
| Net Income | (47.73 M) | ||||
| Total Debt | 18.9 M | ||||
| Book Value Per Share | (1.00) X | ||||
| Cash Flow From Operations | (67.72 M) | ||||
| Earnings Per Share | (4.34) X | ||||
| Market Capitalization | 29.15 M | ||||
| Total Asset | 92.33 M | ||||
| Retained Earnings | (234.81 M) | ||||
| Working Capital | 65.41 M | ||||
About Q32 Bio Performance
By analyzing Q32 Bio's fundamental ratios, stakeholders can gain valuable insights into Q32 Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Q32 Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Q32 Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 221.19 | 232.25 | |
| Return On Tangible Assets | (0.52) | (0.54) | |
| Return On Capital Employed | (0.87) | (0.91) | |
| Return On Assets | (0.52) | (0.54) | |
| Return On Equity | (8.41) | (7.99) |
Things to note about Q32 Bio performance evaluation
Checking the ongoing alerts about Q32 Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Q32 Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Q32 Bio is way too risky over 90 days horizon | |
| Q32 Bio appears to be risky and price may revert if volatility continues | |
| Q32 Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (48.15 M). | |
| Q32 Bio generates negative cash flow from operations | |
| About 70.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Q32 Bio Inc. stock trendline breakdown - Portfolio Update Summary Daily Stock Trend Watchlist - newser.com |
- Analyzing Q32 Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Q32 Bio's stock is overvalued or undervalued compared to its peers.
- Examining Q32 Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Q32 Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Q32 Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Q32 Bio's stock. These opinions can provide insight into Q32 Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |